| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Plexus Biomedical Raises $2 Million
Posted on 07/28/2007 00:17:22 | Link | Post Comment
by Sara Calabro
Med Tech Sentinel
Plexus Biomedical, a small device company based in Oakland, TN, has raised $2 million from individual investors, according to an exclusive report by TechJournal South.
The company’s CEO, David Burton, was tight lipped about Plexus’ technology, but research by TechJournal on clinicaltrials.gov uncovered a study by Plexus Biomedical and the University of Tennessee Health Science Center of the HEM-AVERT Perianal Stablizer, a device designed to reduce the occurrence or severity of hemorrhoids during childbirth.
According to clinicaltrials.gov, the HEM-AVERT Perianal Stablizer “is both non-invasive and poses a non-significant risk. It is classified as a manual, general instrument with no specific indications, but has a general indication of stabilizing pressure.”
The study description says there is currently no preventative treatment for the 9-34% of vaginal births that cause hemorrhoids. TechJournal says the study has enrolled 300 patients and is scheduled to start this month.
Med Tech Sentinel is a regular contributor to BioHealth Investor
________________
Med Tech Sentinel
Plexus Biomedical, a small device company based in Oakland, TN, has raised $2 million from individual investors, according to an exclusive report by TechJournal South.
The company’s CEO, David Burton, was tight lipped about Plexus’ technology, but research by TechJournal on clinicaltrials.gov uncovered a study by Plexus Biomedical and the University of Tennessee Health Science Center of the HEM-AVERT Perianal Stablizer, a device designed to reduce the occurrence or severity of hemorrhoids during childbirth.
According to clinicaltrials.gov, the HEM-AVERT Perianal Stablizer “is both non-invasive and poses a non-significant risk. It is classified as a manual, general instrument with no specific indications, but has a general indication of stabilizing pressure.”
The study description says there is currently no preventative treatment for the 9-34% of vaginal births that cause hemorrhoids. TechJournal says the study has enrolled 300 patients and is scheduled to start this month.
Med Tech Sentinel is a regular contributor to BioHealth Investor
________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- Real Estate Marketing Blog
- Morpheus Trading
- Alpha Trends
- Millionaire Now! by Larry Nusbaum
- Random Roger's Big Picture
- Biiwii.com Notes
Examples
ATM Wallstreet - Mon Oct 06, 2008 03:39PM
Made several great trades today. Traded the QID, QQ [read more]
Made several great trades today. Traded the QID, QQ [read more]
ATM Wallstreet - Sat Oct 04, 2008 10:41PM
When I first started Day Trading I traded anything that [read more]
When I first started Day Trading I traded anything that [read more]
Morpheus Trading - Thu Oct 02, 2008 08:58AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
<< My Home | TheMoneyBlogs Home